✦ LIBER ✦

Effect of zinc on hyperammonemia in sickle cell anemia subjects

✍ Scribed by Dr. Ananda S. Prasad; Parviz Rabbani; James A. Warth

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 268 KB
Volume: 7
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830070404

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

An increase in plasma ammonia level in human volunteers on restricted zinc intake, and in zinc‐deficient rats, has recently been reported. Inasmuch as zinc deficiency has been observed in sickle cell anemia patients, we measured plasma ammonia levels in such subjects. In this report we document hyperammonemia in sickle cell anemia patients that was corrected with zinc therapy.

📜 SIMILAR VOLUMES

Effect of zinc supplementation on serum

Effect of zinc supplementation on serum testosterone level in adult male sickle cell anemia subjects

✍ Ananda S. Prasad; Ali A. Abbasi; Parviz Rabbani; Elizabeth Dumouchelle 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 2 views

## Abstract Previously, we have documented primary testicular failure in adult male subjects with sickle cell anemia. We have also reported the occurrence of zinc deficiency and suggested that androgen deficiency may be related to zinc deficiency in such patients. In this study, we present data wit

Cost-effectiveness of hydroxyurea in sic

Cost-effectiveness of hydroxyurea in sickle cell anemia

✍ Moore, Richard D.; Charache, Samuel; Terrin, Michael L.; Barton, Franca B.; Ball 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 2 views

The Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH) demonstrated the efficacy of hydroxyurea in reducing the rate of painful crises compared to placebo. We used resource utilization data collected in the MSH to determine the cost-effectiveness of hydroxyurea. The MSH was a randomized, p

Rituximab as an effective treatment of h

Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia

✍ Claude Bachmeyer; Jacqueline Maury; Antoine Parrot; Dora Bachir; Katia Stankovic 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

To the Editor: Erythrocytapheresis is an established therapy for the prevention of stroke in sickle cell disease [1]. We report its use in the prevention of recurrent acute coronary syndromes. A 50-year-old woman, with homozygous sickle cell disease presented in December 2005 with central chest pai

Effects of hydroxyurea in a population o

Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia

✍ Perla Vicari; Adriana Barretto de Mello; Maria Stella Figueiredo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Net renal tubular reabsorption of zinc i

Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia

✍ Vilma A. Yuzbasiyan-Gurkan; George J. Brewer; Arthur J. Vander; Michael J. Guent 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 1 views

Effect of zinc supplementation on incide

Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD)

✍ Prasad, Ananda S.; Beck, Frances W.J.; Kaplan, Joseph; Chandrasekar, Pranatharth 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 1 views

Zinc deficiency is a common nutritional problem in adult sickle-cell disease (SCD) patients. Hyperzincuria and increased requirement of zinc due to continued hemolysis in SCD are probable bases for zinc deficiency in these patients. Zinc deficiency affects adversely T-helper 1 (TH 1 ) functions and